Neogene Therapeutics Raises $110 Million Series A Financing to Develop Next-Generation Fully Personalized Neo-Antigen T Cell Receptor (TCR) Therapies

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/33zPWoq
via IFTTT